RNU6-210P

Across TCGA pan-cancer cohorts, RNU6-210P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU6-210P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RNU6-210P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-210P expression acts as an unfavorable survival marker.

OV, BRCA, and STAD are the cancer types where RNU6-210P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	II,III,IV	0.249	0.693	<.001	108	view →
BRCA	OS	Tertile	III,IV	0.106	0.906	<.001	96	view →
STAD	OS	Tertile	IV	0.074	0.496	.002	72	view →
UCEC	OS	Tertile	III,IV	0.053	0.588	.005	72	view →
ESCA	OS	Tertile	II,III,IV	0.284	0.690	.001	36	view →
LIHC	OS	Tertile	All	0.015	0.784	<.001	36	view →
THYM	DFS	Tertile	All	0.075	0.885	<.001	27	view →
LUSC	OS	Tertile	II,III,IV	0.250	0.778	.007	24	view →
SARC	DFS	Tertile	All	0.163	0.613	.007	18	view →
KIRC	OS	Tertile	All	0.269	0.659	.013	15	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU6-210P–OV (OS)

Open the OV breakdown →